Treatment of lower urinary tract symptoms in children with constipation using tegaserod therapy

UroToday International Journal

Volumn 3, Issue 3, 2010, Pages

  Franco, Israel ^a   Cagliostro, Stephen ^a   Collett Gardere, Therese ^a   Kearins, Mary ^a   Zelkovic, Paul ^a   Dyer, Lori ^a   Reda, Edward F ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Children; Constipation; Lower urinary tract symptoms; Serotonin or 5 HT; Tegaserod

Indexed keywords

EID: 77954409969     PISSN: None     EISSN: 19394810     Source Type: Journal    
DOI: 10.3834/uij.1944-5784.2010.06.17     Document Type: Review

References (24)

1. Neveus T, von Gontard A, Hoebeke P, et al. The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children's Continence Society. J Urol. 2006;176(1):314-324.
2. Loening-Baucke V. Urinary incontinence and urinary tract infection and their resolution with treatment of chronic constipation of childhood. Pediatrics. 1997;100(2 Pt 1):228-232.
3. Miyazato M, Sugaya K, Nishijima S, Ashitomi K, Ohyama C, Ogawa Y. Rectal distention inhibits bladder activity via glycinergic and GABAergic mechanisms in rats. J Urol. 2004;171(3):1353-1356.
4. Jia H, Zhang K, Zhang S, Yuan Z, Bai Y, Wang W. Quantitative analysis of sacral parasympathetic nucleus innervating the rectum in rats with anorectal malformation. J Pediatr Surg. 2007;42(9):1544-1548.
5. Fidelholtz J, Smith W, Rawls J, et al. Safety and tolerability of tegaserod in patients with irritable bowel syndrome and diarrhea symptoms. Am J Gastroenterol. 2002;97(5):1176-1181.
6. Chang L. Brain responses to visceral and somatic stimuli in irritable bowel syndrome: a central nervous system disorder? Gastroenterol Clin North Am. 2005;34(2):271-279.
7. Kamm MA. Pharmacological treatment of irritable bowel syndrome--from concept to sales. Eur J Surg Suppl. 2002;587:10-15.
8. Waring WS, Chui M, Japp A, Nicol EF, Ford MJ. Autonomic cardiovascular responses are impaired in women with irritable bowel syndrome. J Clin Gastroenterol. 2004;38(8):658-663.
9. Koff SA, Wagner TT, Jayanthi VR. The relationship among dysfunctional elimination syndromes, primary vesicoureteral reflux and urinary tract infections in children. J Urol. 1998;160(3):1019-1022.
10. Loening-Baucke V. Prevalence rates for constipation and faecal and urinary incontinence. Arch Dis Child. 2007;92(6):486-489.
11. Franco I. Overactive bladder in children. Part 1: Pathophysiology. J Urol. 2007;178(3 Pt 1):761-768.
12. Franco I. Overactive bladder in children. Part 2: Management. J Urol. 2007;178(3 Pt 1):769-774.
13. Chase JW, Homsy Y, Siggaard C, Sit F, Bower WF. Functional constipation in children. J Urol. 2004;171(6 Pt 2):2641-2643.
14. Christianson JA, Liang R, Ustinova EE, Davis BM, Fraser MO, Pezzone MA. Convergence of bladder and colon sensory innervation occurs at the primary afferent level. Pain. 2007;128(3):235-243.
15. Pezzone MA, Liang R, Fraser MO. A model of neural cross-talk and irritation in the pelvis: implications for the overlap of chronic pelvic pain disorders. Gastroenterology. 2005;128(7):1953-1964.
16. Ustinova EE, Fraser MO, Pezzone MA. Cross-talk and sensitization of bladder afferent nerves. Neurourol Urodyn. 2010;29(1):77-81.
17. Ismair MG, Kullak-Ublick GA, Blakely RD, Fried M, Vavricka SR. Tegaserod inhibits the serotonin transporter SERT. Digestion. 2007;75(2-3):90-95.
18. Lucas G, Rymar VV, Du J, et al. Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action. Neuron. 2007;55(5):712-725.
19. Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology. 2007;132(1):397-314.
20. Sabate JM, Bouhassira D, Poupardin C, Wagner A, Loria Y, Coffin B. Sensory signalling effects of tegaserod in patients with irritable bowel syndrome with constipation. Neurogastroenterol Motil. 2008;20(2):134-141.
21. Hammerle CW, Surawicz CM. Updates on treatment of irritable bowel syndrome. World J Gastroenterol. 2008;14(17):2639-2649.
22. Evans BW, Clark WK, Moore DJ, Whorwell PJ. Tegaserod for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2004;(1):CD003960.
23. Warne SA, Godley ML, Wilcox DT. Surgical reconstruction of cloacal malformation can alter bladder function: a comparative study with anorectal anomalies. J Urol. 2004;172(6 Pt 1):2377-2381.
24. Ustinova EE, Fraser MO, Pezzone MA. Colonic irritation in the rat sensitizes urinary bladder afferents to mechanical and chemical stimuli: an afferent origin of pelvic organ cross-sensitization. Am J Physiol Renal Physiol. 2006;290(6):F1478-F1487.